Literature DB >> 2158882

Leukotriene B4 potentiates colonic ulceration in the rat.

J L Wallace1, C M Keenan.   

Abstract

The ability of various leukotrienes, platelet-activating factor and N-formyl-methyl-leucyl-phenylalanine to augment colonic damage induced by 30% ethanol was investigated in the rat. Each of the mediators was tested at a dose of 2 nmol, administered intracolonically in the ethanol vehicle. When colonic damage was assessed 72 hr later, only leukotriene B4 significantly augmented damage compared to the controls. The incidence of ulcers increased from 35% in the control group to 90% in the group receiving leukotriene B4. Leukotriene B4 administration also resulted in significant increases in colonic myeloperoxidase activity and colonic leukotriene B4 synthesis. To assess the possible contribution of infiltrating neutrophils to the increase in colonic leukotriene B4 synthesis that accompanies colonic inflammation, colitis was induced in normal and neutropenic rats by intracolonic administration of trinitrobenzene sulfonic acid. Neutropenia was achieved by treatment with an antineutrophil serum. In the neutropenic animals killed 4 hr after induction of colitis significant changes in leukotriene B4 synthesis were not observed, whereas a fourfold increase was observed in the controls. From these studies we conclude the following: (1) leukotriene B4, at a dose of 2 nmol, can significantly potentiate the colonic ulceration induced by 30% ethanol; (2) this action of leukotriene B4 is not shared by the same dose of the other inflammatory mediators tested; and (3) infiltrating neutrophils are the major source of colonic leukotriene B4 synthesis in a rat model of colitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2158882     DOI: 10.1007/BF01540411

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4.

Authors:  E A Lobos; P Sharon; W F Stenson
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

2.  Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Gastroenterology       Date:  1986-10       Impact factor: 22.682

3.  Is there a role for leukotrienes as mediators of ethanol-induced gastric mucosal damage?

Authors:  J L Wallace; P L Beck; G P Morris
Journal:  Am J Physiol       Date:  1988-01

4.  Studies of leukotriene B4-specific binding and function in rat polymorphonuclear leukocytes: absence of a chemotactic response.

Authors:  R A Kreisle; C W Parker; G L Griffin; R M Senior; W F Stenson
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

5.  The chemotactic peptide N-formyl methionyl-leucyl-phenylalanine increases mucosal permeability in the distal ileum of the rat.

Authors:  C von Ritter; E Sekizuka; M B Grisham; D N Granger
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

6.  Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease.

Authors:  N K Boughton-Smith; J L Wallace; B J Whittle
Journal:  Agents Actions       Date:  1988-08

7.  L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor.

Authors:  J Gillard; A W Ford-Hutchinson; C Chan; S Charleson; D Denis; A Foster; R Fortin; S Leger; C S McFarlane; H Morton
Journal:  Can J Physiol Pharmacol       Date:  1989-05       Impact factor: 2.273

8.  Leukotriene B4, polymorphonuclear leukocytes and inflammatory exudates in the rat.

Authors:  A W Ford-Hutchinson; G Brunet; P Savard; S Charleson
Journal:  Prostaglandins       Date:  1984-07

9.  Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.

Authors:  P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682

10.  An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis.

Authors:  J L Wallace; C M Keenan
Journal:  Am J Physiol       Date:  1990-04
View more
  12 in total

1.  Experimental ulcerative colitis impairs antioxidant defense system in rat intestine.

Authors:  N Nieto; M I Torres; M I Fernández; M D Girón; A Ríos; M D Suárez; A Gil
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

2.  Mucosal factors inducing neutrophil movement in ulcerative colitis: the role of interleukin 8 and leukotriene B4.

Authors:  A T Cole; B J Pilkington; J McLaughlan; C Smith; M Balsitis; C J Hawkey
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

3.  Experimental colitis alters visceromotor response to colorectal distension in awake rats.

Authors:  O Morteau; T Hachet; M Caussette; L Bueno
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

4.  Gastric secretion of platelet activating factor and precursors in healthy humans: effect of pentagastrin.

Authors:  I Sobhani; Y Denizot; S Hochlaf; D Rigaud; J Vatier; J Benveniste; M J Lewin; M Mignon
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

5.  Role of neutrophils in acetic acid-induced colitis in rats.

Authors:  T Yamada; B J Zimmerman; R D Specian; M B Grisham
Journal:  Inflammation       Date:  1991-10       Impact factor: 4.092

6.  Prevention and reversal of experimental colitis by a monoclonal antibody which inhibits leukocyte adherence.

Authors:  J L Wallace; A Higa; G W McKnight; D E MacIntyre
Journal:  Inflammation       Date:  1992-08       Impact factor: 4.092

Review 7.  Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs.

Authors:  J Martel-Pelletier; D Lajeunesse; P Reboul; J-P Pelletier
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

8.  Effects of diet on experimentally induced intestinal ulcers in rats: morphology and tissue leukotrienes.

Authors:  T Matsumoto; M Iida; F Kuroki; K Hizawa; H Koga; M Fujishima
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

9.  Phorbol myristate acetate ex vivo model of enhanced colonic epithelial permeability. Reactive oxygen metabolite and protease independence.

Authors:  M C Berin; M G Buell
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

10.  Colorectal leukotriene B4 synthesis in vitro in inflammatory bowel disease: inhibition by the selective 5-lipoxygenase inhibitor BWA4C.

Authors:  A B Hawthorne; N K Boughton-Smith; B J Whittle; C J Hawkey
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.